Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;64(7):503-10.
doi: 10.1002/syn.20755.

Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice

Affiliations

Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice

Jennifer Pfaffly et al. Synapse. 2010 Jul.

Abstract

Peripheral and central leptin administration have been shown to mediate central dopamine (DA) signaling. Leptin-receptor deficient rodents show decreased DA D2 receptor (D2R) binding in striatum and unique DA profiles compared to controls. Leptin-deficient mice show increased DA activity in reward-related brain regions. The objective of this study was to examine whether basal D2R-binding differences contribute to the phenotypic behaviors of leptin-deficient ob/ob mice, and whether D2R binding is altered in response to peripheral leptin treatment in these mice. Leptin decreased body weight, food intake, and plasma insulin concentration in ob/ob mice but not in wild-type mice. Basal striatal D2R binding (measured with autoradiography [(3)H] spiperone) did not differ between ob/ob and wild-type mice but the response to leptin did. In wild-type mice, leptin decreased striatal D2R binding, whereas, in ob/ob mice, leptin increased D2R binding. Our findings provide further evidence that leptin modulates D2R expression in striatum and that these effects are genotype/phenotype dependent.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Mean (+SEM) Weight Gain Before and After Leptin Treatment
Mean (+SEM) daily body weight in ob/ob and wild-type mice before and after treatment with vehicle or leptin. (*) wt-veh and wt-le mice weighed significantly less than ob-veh and ob-le mice before treatment. (ˆ) wt-veh and wt-le mice weighed significantly less than ob-veh and ob-le mice after treatment. (∼) wt-le and ob-veh mice weighed significantly more post-treatment and ob-le mice weighed significantly less post-treatment.
Figure 2
Figure 2. Mean (+SEM) Food Intake During 8 Day Leptin Treatment
Mean (+SEM) daily food intake in ob/ob and wild-type mice during the treatment period. (*) ob-le mice showed significantly lower food intake compared to ob-veh mice.
Figure 3
Figure 3. Mean (+SEM) plasma Leptin
Mean (+SEM) plasma leptin concentrations in ob/ob and wild-type mice after treatment with vehicle or leptin. (*) wt-le mice had significantly greater plasma leptin levels than wt-veh mice. (ˆ) ob-le mice had significantly greater plasma leptin levels than ob-veh mice.
Figure 4
Figure 4. Mean (+SEM) plasma Insulin
Mean (+SEM) plasma insulin concentrations in ob/ob and wild-type mice after treatment with vehicle or leptin. (*) wt-veh mice had significantly lower plasma insulin levels than ob-veh mice (ˆ) ob-le mice had significantly lower plasma insulin levels than ob-veh mice.
Figure 5
Figure 5. Mean (+SEM) [3H] spiperone D2R binding in ob/ob and wild-type mice after treatment with leptin or vehicle
Mean (+SEM) [3H] spiperone D2R binding in ob/ob and wild-type mice in the CPu and NAc after treatment with vehicle or leptin. Statistically significant differences between are denoted by the (*) symbol and connector lines.

Similar articles

Cited by

References

    1. Baldo BA, Kelley AE. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 2007;191(3):439–59. - PubMed
    1. Baskin DG, Breininger JF, Bonigut S, Miller MA. Leptin binding in the arcuate nucleus is increased during fasting. Brain Res. 1999;828(1-2):154–8. - PubMed
    1. Brunetti L, Michelotto B, Orlando G, Vacca M. Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings. Eur J Pharmacol. 1999;372(3):237–40. - PubMed
    1. Carelli RM. The nucleus accumbens and reward: neurophysiological investigations in behaving animals. Behav Cogn Neurosci Rev. 2002;1(4):281–96. - PubMed
    1. Cincotta AH, Meier AH. Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatment. Life Sci. 1989;45(23):2247–54. - PubMed

Publication types

MeSH terms